Company Spark Therapeutics, Inc.
Equities
US84652J1034
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ron Philip
CEO | Chief Executive Officer | - | 30/04/17 |
Gallia Levy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 50 | 24/09/17 | |
Blake Sprayberry
PRN | Corporate Officer/Principal | - | - |
Chris Stevens
PRN | Corporate Officer/Principal | - | 31/12/21 |
Corporate Officer/Principal | - | 31/12/16 | |
Corporate Officer/Principal | - | 15/11/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 16/12/19 |
Bruce Resnick
BRD | Director/Board Member | - | 16/12/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,944,971 | 36,835,813 ( 94.58 %) | 421,677 ( 1.083 %) | 94.58 % |
Company contact information
Spark Therapeutics, Inc.
3737 Market Street Suite 1300
19104, Philadelphia
+215 220 9300
http://www.sparktx.comSector
1st Jan change | Capi. | |
---|---|---|
-2.17% | 103B | |
+1.83% | 95.28B | |
+2.82% | 22.15B | |
-15.88% | 21.02B | |
-8.56% | 18.15B | |
-41.01% | 16.73B | |
-14.25% | 16.05B | |
+4.28% | 13.68B | |
+32.52% | 12.17B |